Current state of Alzheimer’s fluid biomarkers

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinic...

Full description

Saved in:
Bibliographic Details
Published in:Acta Neuropathol
Main Authors: Molinuevo, José Luis, Ayton, Scott, Batrla, Richard, Bednar, Martin M., Bittner, Tobias, Cummings, Jeffrey, Fagan, Anne M., Hampel, Harald, Mielke, Michelle M., Mikulskis, Alvydas, O’Bryant, Sid, Scheltens, Philip, Sevigny, Jeffrey, Shaw, Leslie M., Soares, Holly D., Tong, Gary, Trojanowski, John Q., Zetterberg, Henrik, Blennow, Kaj
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280827/
https://ncbi.nlm.nih.gov/pubmed/30488277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-018-1932-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items